RxDoctor Payments Data

Katherine Atwood, PA

Medical · Sebastian, FLNPI 1376900084

Payments from drug & device makers

$7,712in general payments, 2019–2025

Across 350 payments — averaging $22.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$3K
  • AbbVie$813
  • Regeneron Healthcare Solutions, Inc.$618
  • E.r. Squibb & Sons, L.L.C.$399
  • Amgen$348
  • UCB, Inc.$345
  • plus $2K from 20 others

What the payments were for

  • Consulting fees$90012%
  • Food & beverage$6,33582%
  • Education$4776%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,712 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$423,622
Medicare patients
1,179
Services billed
8,668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab18$96,280
Taltz AutoinjectorIxekizumab11$77,752
JubliaEfinaconazole29$28,929
VtamaTapinarof14$21,642
ZoryveRoflumilast12$11,610
Fluorouracil122$9,078
Clobetasol Propionate134$6,878
Ketoconazole328$4,974
Triamcinolone Acetonide346$4,862
Doxycycline Hyclate125$2,851
Mometasone Furoate122$2,458
Mupirocin257$1,961
Clindamycin Phosphate53$1,426
Hydrocortisone153$1,169
Azelaic Acid13$1,027

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$107$28,92929 claims
Dermavant Sciences, Inc.Vtama$329$21,64214 claims
Arcutis Biotherapeutics, Inc.Zoryve$129$11,61012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,031 medical providers in Florida.

Other medical in Sebastian

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →